XRN (XRN) Stock Price & Analysis
XRN (XRN) rose 1.20% to USD 36.96 as of September 8, 2026 at 04:59 UTC, according to Nexqual real-time market data.
XRN last closed at USD 36.52; the session ranged USD 36.6–37.41 on volume of 98,384 shares. Market capitalization is $535.19M, with a 52-week range of USD 29.05–39.93 (NYQ). Source: Nexqual, September 8, 2026 at 04:59 UTC.
Key Statistics (as of September 8, 2026 at 04:59 UTC)
| Price | USD 36.96 |
|---|---|
| Change | ▲ 1.20% (up) |
| Previous Close | USD 36.52 |
| Open | USD 36.36 |
| Day Range | USD 36.6 – 37.41 |
| 52-Week Range | USD 29.05 – 39.93 |
| Volume | 98,384 shares |
| Market Cap | $535.19M |
| Exchange | NYQ |
Technical Analysis (XRN)
Nexqual's technical model rates XRN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:59 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 48.92 (neutral) |
| vs SMA50 | Above (USD 36.8) |
| MACD | 0.1 (positive) |
Analyst Ratings (XRN)
Wall Street analysts rate XRN "None" based on 8 analysts, with a mean price target of USD 38 (range USD 9–46), per Nexqual as of September 8, 2026 at 04:59 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 38 |
| High Target | USD 46 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 4 / 6 / 0 |
Earnings (XRN)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD -0.85 |
| Revenue Estimate | $39.31M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.65 vs est -0.25 ▼ miss |
| 2026-03-31 | USD -0.06 vs est 0.01 ▼ miss |
| 2025-12-31 | USD -0.02 vs est 0.13 ▼ miss |
| 2025-09-30 | USD 0.01 vs est 0.05 ▼ miss |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
Financials & Fundamentals (XRN)
| Total Revenue | $153.35M |
|---|---|
| Revenue Growth (YoY) | +4.80% |
| Gross Margin | +100.00% |
| Operating Margin | +23.17% |
| Profit Margin | +37.79% |
| ROE | +10.38% |
| Debt / Equity | 94.51 |
| Current Ratio | 1.26 |
| Total Cash | $21.56M |
| Total Debt | $646.51M |
| Free Cash Flow | $95.00M |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
Financial Health Score (XRN)
Nexqual rates XRN's overall financial health "Solid" across five dimensions, as of September 8, 2026 at 04:59 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Operating margin 23% |
| Balance Sheet | Mixed — $22M cash vs $647M debt |
| Cash Flow | Strong — FCF $95M, 64% margin |
| Efficiency | Mixed — ROE 10%, ROA 1.8% |
Ownership (XRN)
| Insider Ownership | +6.48% |
|---|---|
| Institutional Ownership | +78.00% |
| Shares Outstanding | 13.24M |
| Float | 12.23M |
| Short % of Float | +6.94% |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
From XRN's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHCT | Community Healthcare Trust Inco | USD 15 | ▲ 0.67% |
| DEA | Easterly Government Properties, | USD 24.31 | ▼ 0.73% |
| SBRA | Sabra Health Care REIT, Inc. | USD 20.78 | ▼ 0.38% |
| CTRE | CareTrust REIT, Inc. | USD 39.01 | ▼ 1.42% |
| GNL | Global Net Lease, Inc. | USD 9.12 | ▼ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:59 UTC. This page is informational and not investment advice.